Company logo

DMTK - DermTech, Inc.

NASDAQ -> Healthcare -> Diagnostics & Research
La Jolla, United States
Type: Equity

DMTK price evolution
DMTK
(in millions $) 30 Sep 2022 30 Jun 2022 31 Mar 2022 31 Dec 2021
Current assets
Cash $98.97 $123.8 $148.08 $179.91
Short term investments $53.64 $53.46 $54.05 $48.45
Net receivables $6.1 $5.96 $5 $3.85
Inventory $1.39 $1.43 $0.76 $0.48
Total current assets $160.83 $183.87 $208.12 $232.82
Long term investments
Property, plant & equipment $29.59 $28.61 $28.21 $12.29
Goodwill & intangible assets
Total noncurrent assets $33.23 $32.25 $31.4 $15.48
Total investments $53.64 $53.46 $54.05 $48.45
Total assets $194.06 $216.11 $239.52 $248.31
Current liabilities
Accounts payable $3 $0.86 $1.57 $2.88
Deferred revenue $0.42 $1.31 $1.35 $1.38
Short long term debt $1.71 $1.83 $1.81 $1.57
Total current liabilities $16.99 $15.09 $14.42 $12.18
Long term debt $22.07 $22.42 $21.49 $6.28
Total noncurrent liabilities $22.09 $22.45 $21.62 $6.43
Total debt $23.78 $24.25 $23.3 $7.86
Total liabilities $39.08 $37.53 $36.04 $18.61
Shareholders' equity
Retained earnings -$294.82 -$266.05 -$236.47 -$206.36
Other shareholder equity -$1.09 -$0.86 -$0.69 -$0.12
Total shareholder equity $154.99 $178.58 $203.48 $229.7
(in millions $) 31 Dec 2021 31 Dec 2020 31 Dec 2019 31 Dec 2018
Current assets
Cash $179.91 $24.25 $15.37 $0.45
Short term investments $48.45 $39.53
Net receivables $3.85 $1.48 $0.68 $0.68
Inventory $0.48 $0.1 $0.04 $0.04
Total current assets $232.82 $66.88 $17.15 $0.54
Long term investments $146.35
Property, plant & equipment $12.29 $2.73 $0.98 $0.98
Goodwill & intangible assets
Total noncurrent assets $15.48 $2.9 $1.06 $146.35
Total investments $48.45 $39.53 $146.35
Total assets $248.31 $69.78 $18.21 $146.89
Current liabilities
Accounts payable $2.88 $1.57 $1.61 $0.03
Deferred revenue $1.38 $1.54 $1.39 $1.39
Short long term debt $1.57 $0.11 $0.01
Total current liabilities $12.18 $5.42 $5.72 $0.04
Long term debt $6.28 $0.23
Total noncurrent liabilities $6.43 $0.86 $5.03 $5.03
Total debt $7.86 $0.34 $0.01
Total liabilities $18.61 $6.29 $5.72 $5.07
Shareholders' equity
Retained earnings -$206.36 -$126.36 -$91.11 $0.85
Other shareholder equity -$0.12 -$0
Total shareholder equity $229.7 $63.49 $12.49 $5
(in millions $) 30 Sep 2022 30 Jun 2022 31 Mar 2022 31 Jan 2022
Revenue
Total revenue $3.57 $4.23 $3.72
Cost of revenue $3.69 $3.27 $3.55
Gross Profit -$0.12 $0.96 $0.16
Operating activities
Research & development $5.7 $6.92 $6.34
Selling, general & administrative $23.44 $23.88 $24.02
Total operating expenses $29.14 $30.79 $30.36
Operating income -$29.26 -$29.83 -$30.19
Income from continuing operations
EBIT -$28.77 -$29.58 -$30.11
Income tax expense
Interest expense
Net income
Net income -$28.77 -$29.58 -$30.11
Income (for common shares) -$28.77 -$29.58 -$30.11
(in millions $) 31 Jan 2022 31 Dec 2020 31 Dec 2019 31 Dec 2018
Revenue
Total revenue $5.88 $3.36
Cost of revenue $5.98 $3.3
Gross Profit -$0.1 $0.06
Operating activities
Research & development $5.29 $2.5
Selling, general & administrative $29.9 $15.17
Total operating expenses $35.19 $17.66 $0.31
Operating income -$35.29 -$17.61 -$0.31
Income from continuing operations
EBIT -$35.29 -$17.03 $0.86
Income tax expense
Interest expense -$0.04 $2.66
Net income
Net income -$35.25 -$19.69 $0.86
Income (for common shares) -$35.25 -$19.69 $0.86
(in millions $) 30 Sep 2022 30 Jun 2022 31 Mar 2022 31 Dec 2021
Net income -$28.77 -$29.58 -$30.11 -$26.05
Operating activities
Depreciation $1.1 $1.07 $0.81 $0.73
Business acquisitions & disposals
Stock-based compensation $4.94 $4.84 $3.89 $3.83
Total cash flows from operations -$24.8 -$24.41 -$24.82 -$22.68
Investing activities
Capital expenditures -$0.01 -$0.71 -$0.65 -$1.06
Investments -$0.45 $0.85 -$6.89 -$3.47
Total cash flows from investing -$0.47 $0.14 -$7.53 -$4.52
Financing activities
Dividends paid
Sale and purchase of stock $0.48 $0.01 $0.57 $0.12
Net borrowings -$0.04 -$0.02 -$0.04 -$0.09
Total cash flows from financing $0.43 -$0.01 $0.53 $0.03
Effect of exchange rate
Change in cash and equivalents -$24.83 -$24.27 -$31.83 -$27.18
(in millions $) 31 Dec 2021 31 Dec 2020 31 Dec 2019 31 Dec 2018
Net income -$78.33 -$35.25 -$19.69 $0.86
Operating activities
Depreciation $2.3 $0.49 $0.09
Business acquisitions & disposals
Stock-based compensation $13.28 $4.97 $1.3
Total cash flows from operations -$62.11 -$28.68 -$17.79 -$0.37
Investing activities
Capital expenditures -$2.72 -$1.83 -$0.21
Investments -$9.79 -$39.51 -$145.19
Total cash flows from investing -$12.51 -$41.34 -$0.21 -$145.19
Financing activities
Dividends paid
Sale and purchase of stock $230.45 $44.31 $20.74 $146.49
Net borrowings -$0.17 -$0.01 $2.08 -$0.32
Total cash flows from financing $230.28 $78.9 $28.62 $145.99
Effect of exchange rate
Change in cash and equivalents $155.66 $8.87 $10.62 $0.42
Fundamentals
Market cap $157.71M
Enterprise value $82.52M
Shares outstanding 30.21M
Revenue N/A
EBITDA N/A
EBIT N/A
Net Income N/A
Revenue Q/Q 17.92%
Revenue Y/Y N/A
P/E ratio N/A
EV/Sales N/A
EV/EBITDA N/A
EV/EBIT N/A
P/S ratio N/A
P/B ratio 1.01
Book/Share 5.17
Cash/Share 3.28
EPS N/A
ROA N/A
ROE N/A
Debt/Equity 0.08
Net debt/EBITDA N/A
Current ratio 9.47
Quick ratio 9.39